Panbela Therapeutics Stock Earnings Per Share
| PBLADelisted Stock | USD 2.06 0.11 5.07% |
Panbela Therapeutics fundamentals help investors to digest information that contributes to Panbela Therapeutics' financial success or failures. It also enables traders to predict the movement of Panbela Stock. The fundamental analysis module provides a way to measure Panbela Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Panbela Therapeutics stock.
Panbela |
Panbela Therapeutics Company Earnings Per Share Analysis
Panbela Therapeutics' Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Panbela Therapeutics Earnings Per Share | (157.02) X |
Most of Panbela Therapeutics' fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Panbela Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
CompetitionAccording to the company disclosure, Panbela Therapeutics has an Earnings Per Share of -157.02 times. This is 1975.99% lower than that of the Biotechnology sector and notably higher than that of the Health Care industry. The earnings per share for all United States stocks is notably higher than that of the company.
Panbela Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Panbela Therapeutics' direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Panbela Therapeutics could also be used in its relative valuation, which is a method of valuing Panbela Therapeutics by comparing valuation metrics of similar companies.Panbela Therapeutics is currently under evaluation in earnings per share category among its peers.
Panbela Fundamentals
| Return On Equity | -7.98 | ||||
| Return On Asset | -1.92 | ||||
| Current Valuation | 8.64 M | ||||
| Shares Outstanding | 3.48 M | ||||
| Shares Owned By Institutions | 0.59 % | ||||
| Number Of Shares Shorted | 106.97 K | ||||
| Price To Book | 3.22 X | ||||
| EBITDA | (34.76 M) | ||||
| Net Income | (34.93 M) | ||||
| Cash And Equivalents | 2.53 M | ||||
| Cash Per Share | 0.12 X | ||||
| Total Debt | 6.84 M | ||||
| Current Ratio | 0.56 X | ||||
| Book Value Per Share | (16.57) X | ||||
| Cash Flow From Operations | (15.28 M) | ||||
| Short Ratio | 0.07 X | ||||
| Earnings Per Share | (157.02) X | ||||
| Target Price | 410.0 | ||||
| Beta | 0.83 | ||||
| Market Capitalization | 3.93 M | ||||
| Total Asset | 4.98 M | ||||
| Retained Earnings | (91.09 M) | ||||
| Working Capital | (6.06 M) | ||||
| Z Score | -49.78 | ||||
| Net Asset | 4.98 M |
About Panbela Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Panbela Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Panbela Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Panbela Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Panbela Stock
If you are still planning to invest in Panbela Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Panbela Therapeutics' history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |